The recipient of a doctor of pharmacy from Long Island University, Babak Bamdad is the director of pharmacy at Lincoln Hospital. Based in Great Neck, New York, Babak Bamdad is a member of the American Association of Pharmaceutical Scientists (AAPS).
AAPS regularly organizes workshops for pharmaceutical scientists to promote learning among members. From May 6 to 7, AAPS will host a workshop at the Hyatt Regency Boston Harbor to connect predictive modelers. Organized with the goal of increasing predictive modeling’s collective impact on pharmaceutical science, the workshop will bring together modelers from various pharma disciplines to advance education and collaboration for the benefit of all.
At the workshop, pharmaceutical scientists from the academic, industry, and regulatory fields will discuss the commonalities and differences of their modeling philosophies and practices. They will also share the tools and techniques underlying current modeling practices across disciplines and discover emerging technologies inspiring the future of predictive modeling. The scientists will also agree on predictive modeling best practices, establish approaches for communicating modeling results to decision makers, and identify opportunities for collaboration and efficiency gains. Attendees will receive session slides after the event.
Babak Bamdad guides the Lincoln Hospital Pharmacy Department in New York as director and chief, and supervises all aspects of department operation. Active with the American Association of Pharmaceutical Scientists, Babak Bamdad has an extensive knowledge of new drugs on the market.
While Tamiflu has long been the most prevalent drug for annual flu shots, a new drug, Xofluza, was recently introduced. Both are marketed by Genentech and priced at around $150 wholesale, with Tamiflu also available in a generic version that costs about $50.
The first new flu drug to receive FDA approval in 20 years, Xofluza acts as an antiviral and usually works to reduce flu symptoms within a day. Common side effects include nausea, diarrhea, and headaches, with some pediatric patients also experiencing irritability and, in rare cases, seizures. The latter effects have caused some physicians to shy away from prescribing Xofluza to children, though the symptoms disappear once the medication is stopped.
Although Xofluza is described as safe, there is some concern in the medical community that it could lead to the formation of an adaptive superbug.
Dr. Babak Bamdad joined Lincoln Hospital in New York City in 2010, and continues to manage activities as chief and director of the pharmacy department. Beyond his work at the hospital, Dr. Babak Bamdad engages with professional organizations, such as the American Association of Pharmaceutical Scientists and the Association of Clinical Research in the Pharmaceutical Industry.
The American Association of Pharmaceutical Scientists' (AAPS) annual meeting, AAPS PharmSci 360, provides five comprehensive educational tracks addressing all aspects of the pharmaceutical sciences. These tracks are further divided into chemical and biomolecule specialties, making for ten total tracks. The Dynamic Solution Center floor has been broken down into sections mirroring these tracks, thereby allowing professionals to easily navigate through hundreds of exhibitors offering dozens of learning opportunities. Educational materials are further streamlined into thousands of scientific posters set up throughout the area, each promoting the most progressive industry research techniques and news.
The vast educational offerings at AAPS PharmSci 360 are complemented by extensive networking opportunities and career development support for managers and administrators. To learn more about the 2019 AAPS PharmSci 360, please visit www.apps.org.
A resident of Greatneck, New York, Babak Bamdad is the chief director of the pharmacy department at Lincoln Hospital. The holder of a doctor of pharmacy, Babak Bamdad is a member of the American Association of Pharmaceutical Scientists (AAPS).
AAPS is dedicated to advancing pharmaceutical sciences, careers, and community. It draws its primary membership from pharmaceutics, biopharmaceutics, and pharmacy. AAPS offers members opportunities to expand their professional knowledge through the AAPS education program.
The AAPS education program offers professional education both online and offline through e-courses, workshops, and live events. The e-courses, facilitated by industry leaders with a goal to provide practical scientific perspectives, cover topics such as biotherapeutic development, pharmacotherapy, and drug pre-formulation. AAPS members get a discount on these courses.
Offline, AAPS education hosts regular workshops where members can interact with fellow pharmaceutical scientists and tackle topics such as dermatological drugs and immune-oncology modeling. The organization has many workshops scheduled for the remainder of the year that cover industry issues.
The chief and director of the pharmacy department at Lincoln Hospital in New York, Babak Bamdad supervises, hires, and trains personnel. In addition to this, Babak Bamdad handles daily practices at the pharmacy, including establishing standards of quality and promoting efficient operations.
Below are three ways to improve efficiency at pharmacies:
1. Streamline movement: Although it may seem pointless, it’s important that pharmacy leaders look at how many steps their pharmacists and technicians take to do their work. Ideally, every tool and resource personnel needs to complete daily tasks must be kept close and on hand. Reducing the number of steps personnel must take streamlines movement and makes them more efficient.
2. Introduce automation: Automated systems are capable of boosting pharmacy efficiency while also improving patient safety. By introducing these systems, pharmacy leaders reduce how much time is spent managing out-of-stock medication and makes refilling scripts easier.
3. Assign tasks: Most of the time, pharmacy personnel juggle multiple tasks throughout their day, such as answering phones and labeling prescriptions. Instead, designate each task to specific workers. For example, having staff members who are only responsible for answering phones keeps other personnel free for filling prescriptions fast.
Babak Bamdad is a respected presence in the New York community who leads the pharmacy department at Lincoln Hospital as director and chief. Supervising operations, Babak Bamdad strives to maintain high levels of department efficiency while complying with federal regulatory mandates. Active with professional organizations, he maintains a strong interest in developments in the pharmaceutical industry.
A recent Business Insider article discussed what is described as the first positive Alzheimer's trial in several years. As presented at the Alzheimer's Association International Conference, Biogen and Eisai completed a phase 2 study for the drug BAN2401 encompassing 800 early Alzheimer's disease patients. The approach involves targeting the beta amyloid proteins that accumulate in brains of those with Alzheimer's disease.
The trial results were a 30 percent reduction of beta amyloid proteins among patients who took the highest dose of BAN2401, as opposed to those receiving placebos. With PET imaging employed in identifying amyloid plaques within the brain, 81 percent of patients taking high doses of BAN2401 improved from amyloid positive to amyloid negative over an 18 month period. With a major clinical milestone achieved, further trials of this novel therapeutic approach are expected to continue.
A graduate of the doctor of pharmacy program at Long Island University, Babak Bamdad has earned the Pharmacy Residency Excellence Award and the Award for Excellence in Medication-Use Safety. The chief and director of the pharmacy department of Lincoln Hospital in New York City since 2010, Babak Bamdad belongs to the American Association of Pharmaceutical Scientists (AAPS).
Founded to promote health on a global scale through the support of scientists in the pharmaceutical industry, AAPS serves members in a diverse range of related fields, including biology, chemistry, and medicine. Every year, the AAPS annual meeting, PharmSci 360, supplies members with an opportunity to network and share ideas.
The 2018 AAPS PharmSci 360 will take place November 4-7 in Washington, DC, at the Walter E. Washington Convention Center. Those who purchase admission to the full conference can attend the welcome and closing receptions, participate in five separate educational tracks covering biomolecular and chemical sciences, and visit an extensive exhibit hall featuring products and services from companies in the pharmaceutical industry.
Since 2010, Babak Bamdad has served as the chief and director of the pharmacy department at Lincoln Hospital in New York. In this role, he oversees operations at the hospital pharmacy and establishes productivity and quality standards. Active in the professional community, Babak Bamdad belongs to industry organizations including the American Association of Pharmaceutical Scientists (AAPS).
As part of its efforts to help pharmaceutical scientists develop new therapies and products, AAPS hosts numerous meetings and conferences throughout the year. The organization’s premier event is PharmSci 360, an annual gathering that welcomes more than 7,000 pharmaceutical professionals from around the world.
At this event, attendees have the opportunity to visit exhibitors, network with colleagues, and learn from thousands of scientific posters. In addition, the event offers five pharmaceutical sciences tracks, including bioanalytics, preclinical development, and clinical pharmacology, through which attendees can advance their knowledge. These tracks are further split into 10 sub-tracks for a more targeted educational experience. Further, PharmSci 360 has numerous career development sessions for administrators and managers.
The 2018 PharmSci 360 event is scheduled for November 4-7 in Washington, DC. It will focus on such topics as chemical drugs, biomolecular drugs, emerging research tools, and clinical pharmacology. The conference will feature several keynote speakers, as well as plenary speakers Stephan Grupp, MD, PhD, and Dany De Grave.
New York-based pharmaceutical professional Babak Bambad has served as the director of the pharmacy department at New York City’s Lincoln Hospital since 2010. As a professional corollary, Babak Bambad maintains membership in the American Association of Pharmaceutical Scientists (AAPS).
In its efforts to advance the knowledge and skills of pharmaceutical scientists, the AAPS oversees a variety of programs and activities focused on education, research, and career development. The organization’s educational offerings include in-person workshops and online learning activities such as webinars and eCourses.
The AAPS currently offers 10 eCourses facilitated by leaders in the pharmaceutical industry. Each online course is self-paced and provides insight from practicing scientists. Course topics include biotherapeutic development, regulatory affairs, and drug discovery and development.
In addition to taking part in live webinars, AAPS members can access a number of archived webinars on the organization’s website. AAPS webinars are available online for three years from the date they were first offered. Members also have the opportunity to offer their own webinars on the site by submitting a proposal to the AAPS.
For more information, visit www.aaps.org.
At Lincoln Medical and Mental Health Center, Babak Bamdad’s primary duties involve establishing and maintaining quality, performance, and productivity standards in accordance with those set by Presentation Medical Center.